StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Alterity Therapeutics's enterprise value was $16.21M on Nov 11, 2026, against $2.72B a year earlier. Over the last 5 years it ranged from -$12.20M to $4.06B, with a median of $415.73M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.21M-99.3%
2025Dec 31, 2025$2.32B+61.3%
2024Dec 31, 2024$1.44B+190.4%
2023Dec 29, 2023$495.51M–
2022Dec 30, 2022-$9.72M-311.4%
2021Dec 31, 2021$4.60M-64.4%
2020Dec 31, 2020$12.90M–
2019Dec 31, 2019-$2.12M-423.5%
2018Dec 31, 2018$654.71K-93.9%
2017Dec 29, 2017$10.66M–
2016Dec 30, 2016-$6.17M–

More Alterity Therapeutics figures

See a number that looks wrong?